Success Story: An Iranian Student Secures NIW Approved with No RFE Through Our Tailored Strategy

Posted by wegreened on August 13, 2025 in NIW, Medicine (Pharmaceutics, Pharmacology, Oncology, Pharmacognosy, Biomedical Engineering, Biomedicine)

Client’s Testimonial:

“Working with NAILG on my EB-2 NIW petition has been a truly exceptional experience. From our very first consultation, the team demonstrated a deep understanding of both my field and the unique nuances of the NIW process. They took the time to understand my research in biomedical engineering and developed a tailored petition that accurately reflected the national importance of my work. I felt supported and confident throughout the process. I’m incredibly grateful for their help and would highly recommend them to anyone pursuing an NIW.”

On March 12^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Student in the Field of Biomedical Engineering (Approval Notice).

General Field: Biomedical Engineering

Position at the Time of Case Filing: Student

Country of Origin: Iran

State of Residence at the Time of Filing: Wisconsin

Approval Notice Date: March 12^th, 2025

Processing Time: 1 year, 3 months, 24 days

Case Summary:

We are proud to share the approval of an I-140 petition under the EB-2 National Interest Waiver (NIW) category for a biomedical engineering expert whose innovative work is transforming how machine learning and deep learning technologies are leveraged in healthcare. The approval recognizes the national value of his contributions, which are designed to improve clinical outcomes, support early disease detection, and optimize healthcare delivery systems.

With an MS degree in mechanical engineering and deep expertise in AI-driven medical analysis, the petitioner has demonstrated a remarkable ability to develop intelligent diagnostic and predictive tools that address complex biomedical challenges. His research focuses on the application of neural networks and data-driven models to improve patient outcomes. These contributions have immediate utility in enhancing medical decision-making and advancing the future of personalized medicine.

Currently engaged in biomedical engineering research in an academic medical setting, he is committed to continuing his work at the intersection of AI and healthcare.

To support the petition, we presented evidence of:

● 2 peer-reviewed journal articles and 1 preprint, which reflect rigorous scientific contributions to leading venues,

● 20 total citations according to Google Scholar, underscoring the growing influence of his work in the field,

● 1 invited peer review, recognizing his subject-matter expertise and professional standing among academic peers.

Additionally, his research has attracted the support of esteemed funding bodies. This backing affirms the national and global importance of his studies and their alignment with critical priorities in health innovation and technological leadership.

We extend our congratulations to this client for securing a favorable NIW decision. Through NAILG, we are honored to support forward-thinking researchers like him whose work bridges advanced machine learning with lifesaving medical outcomes, contributing to both scientific progress and the public good.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%